These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 13233657)

  • 1. The hemolytic effect of primaquine. VII. Biochemical studies of drug-sensitive erythrocytes.
    BEUTLER E; DERN RJ; FLANAGAN CL; ALVING AS
    J Lab Clin Med; 1955 Feb; 45(2):286-95. PubMed ID: 13233657
    [No Abstract]   [Full Text] [Related]  

  • 2. The hemolytic effect of primaquine. IX. Enzymatic abnormalities in primaquine-sensitive erythrocytes.
    SCHRIER SL; KELLERMEYER RW; CARSON PE; ICKES CE; ALVING AS
    J Lab Clin Med; 1958 Jul; 52(1):109-17. PubMed ID: 13549855
    [No Abstract]   [Full Text] [Related]  

  • 3. The hemolytic effect of primaquine. VI. An in vitro test for sensitivity of erythrocytes to primaquine.
    BEUTLER E; DERN RJ; ALVING AS
    J Lab Clin Med; 1955 Jan; 45(1):40-50. PubMed ID: 13233626
    [No Abstract]   [Full Text] [Related]  

  • 4. The hemolytic effect of primaquine. I. The localization of the drug-induced hemolytic defect in primaquine-sensitive individuals.
    DERN RJ; WEINSTEIN IM; LEROY GV; TALMAGE DW; ALVING AS
    J Lab Clin Med; 1954 Feb; 43(2):303-9. PubMed ID: 13130947
    [No Abstract]   [Full Text] [Related]  

  • 5. The hemolytic effect of primaquine. III. A study of primaquine-sensitive erythrocytes.
    BEUTLER E; DERN RJ; ALVING AS
    J Lab Clin Med; 1954 Aug; 44(2):177-84. PubMed ID: 13184225
    [No Abstract]   [Full Text] [Related]  

  • 6. The hemolytic effect of primaquine. V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity.
    DERN RJ; BEUTLER E; ALVING AS
    J Lab Clin Med; 1955 Jan; 45(1):30-9. PubMed ID: 13233625
    [No Abstract]   [Full Text] [Related]  

  • 7. The hemolytic effect of primaquine. XIII. Gradient susceptibility to hemolysis of primaquine-sensitive erythrocytes.
    KELLERMEYER RW; TARLOV AR; SCHRIER SL; CARSON PE; ALVING AS
    J Lab Clin Med; 1961 Aug; 58():225-33. PubMed ID: 13752331
    [No Abstract]   [Full Text] [Related]  

  • 8. The hemolytic effect of primaquine. IV. The relationship of cell age to hemolysis.
    BEUTLER E; DERN RJ; ALVING AS
    J Lab Clin Med; 1954 Sep; 44(3):439-42. PubMed ID: 13201853
    [No Abstract]   [Full Text] [Related]  

  • 9. The hemolytic effect of primaquine. XI. Decreased catalase activity in primaquine-sensitive erythrocytes.
    TARLOV AR; KELLERMEYER RW
    J Lab Clin Med; 1961 Aug; 58():204-16. PubMed ID: 13775336
    [No Abstract]   [Full Text] [Related]  

  • 10. The hemolytic effect of primaquine. X. Aldolase and glyceraldehyde-3-phosphate dehydrogenase activity in primaquine-sensitive erythrocytes.
    SCHRIER SL; KELLERMEYER RW; CARSON PE; ICKES CE; ALVING AS
    J Lab Clin Med; 1959 Aug; 54():232-40. PubMed ID: 14443591
    [No Abstract]   [Full Text] [Related]  

  • 11. The hemolytic effect of primaquine. II. The natural course of the hemolytic anemia and the mechanism of its self-limited character.
    DERN RJ; BEUTLER E; ALVING AS
    J Lab Clin Med; 1954 Aug; 44(2):171-6. PubMed ID: 13184224
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemolytic effect of therapeutic drugs. Clinical considerations of the primaquine-type hemolysis.
    KELLERMEYER RW; TARLOV AR; BREWER GJ; CARSON PE; ALVING AS
    JAMA; 1962 May; 180():388-94. PubMed ID: 14454972
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemolysis and primaquine treatment. Preliminary report].
    Menéndez Capote R; Díaz Pérez L; Luzardo Suárez C
    Rev Cubana Med Trop; 1997; 49(2):136-8. PubMed ID: 9685977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hemolytic effect of primaquine. XV. Role of methemoglobin.
    BREWER GJ; TARLOV AR; KELLERMEYER RW; ALVING AS
    J Lab Clin Med; 1962 Jun; 59():905-17. PubMed ID: 13872969
    [No Abstract]   [Full Text] [Related]  

  • 15. The hemolytic effect of primaquine and related compounds: a review.
    BEUTLER E
    Blood; 1959 Feb; 14(2):103-39. PubMed ID: 13618370
    [No Abstract]   [Full Text] [Related]  

  • 16. The methemoglobin reduction test for primaquine-type sensitivity of erythrocytes. A simplified procedure for detecting a specific hypersusceptibility to drug hemolysis.
    BREWER GJ; TARLOV AR; ALVING AS
    JAMA; 1962 May; 180():386-8. PubMed ID: 13872968
    [No Abstract]   [Full Text] [Related]  

  • 17. The hemolytic effect of primaquine. XIV. Pentose metabolism in primaquine-sensitive erythrocytes.
    KELLERMEYER RW; CARSON PE; SCHRIER SL; TARLOV AR; ALVING AS
    J Lab Clin Med; 1961 Nov; 58():715-24. PubMed ID: 14454971
    [No Abstract]   [Full Text] [Related]  

  • 18. Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway.
    Ganesan S; Chaurasiya ND; Sahu R; Walker LA; Tekwani BL
    Toxicology; 2012 Mar; 294(1):54-60. PubMed ID: 22330256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine.
    Bowman ZS; Oatis JE; Whelan JL; Jollow DJ; McMillan DC
    J Pharmacol Exp Ther; 2004 Apr; 309(1):79-85. PubMed ID: 14724225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consideration of ethics in primaquine therapy against malaria transmission.
    Baird JK; Surjadjaja C
    Trends Parasitol; 2011 Jan; 27(1):11-6. PubMed ID: 20846906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.